Madrid, Spain

Carlos Lamas Peteira

USPTO Granted Patents = 7 

Average Co-Inventor Count = 5.0

ph-index = 4

Forward Citations = 33(Granted Patents)


Company Filing History:


Years Active: 1997-1999

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations by Carlos Lamas Peteira

Introduction

Carlos Lamas Peteira is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of central nervous system activity through his innovative research and patents. With a total of 7 patents, his work has garnered attention in the scientific community.

Latest Patents

Among his latest patents are the developments related to aminoalkyl-indoles and tetrahydro-beta-carbolines. The present invention provides novel tetrahydro-beta-carboline compounds that exhibit useful central nervous system activity. Additionally, it includes tetrahydro-beta-carboline related compounds that serve as useful intermediates and possess beneficial central nervous system activity. The invention outlines formulations and methods for utilizing these novel compounds, which are particularly effective for modulating a 5-HT.sub.2B receptor.

Career Highlights

Carlos Lamas Peteira is currently associated with Eli Lilly and Company, where he continues to advance his research in pharmacology. His work has been instrumental in developing new therapeutic approaches for various neurological conditions.

Collaborations

Throughout his career, Carlos has collaborated with esteemed colleagues such as James E Audia and Stephen Richard Baker. These collaborations have further enriched his research and contributed to the success of his inventions.

Conclusion

Carlos Lamas Peteira's innovative contributions to the field of central nervous system activity highlight his role as a leading inventor. His patents and ongoing research continue to pave the way for advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…